http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006136606-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f8fcfae3dc287066ee4a14f5983cbc9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f6443dbff2d7a50a1fddd4da97de8cf8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b26597d2f25ddd9343c885f15d8c71df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ddcc49fce02910d98126c70fe0065dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-34
filingDate 2006-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a66025932ee4a422c58c57a5aa7e92f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc68bf97dc8767575ab2fd681ad14046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47ec8bd0f2b0533e59e0bd449d4f848f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5a077f37facc1ea01734b1714b5ef07
publicationDate 2007-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006136606-A3
titleOfInvention Oxindole derivatives
abstract The invention describes compounds of the general formula (I-A) or the pharmaceutically acceptable salts thereof, wherein R1, R2, R4 and R5 are herein described, a process for their manufacture, medicaments containing them as well as the use of these compounds as pharmaceutically active agents. The compounds show activity as antiproliferative agents and may be especially useful for the treatment of cancer.
priorityDate 2005-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4020179-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03078394-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2759935-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S55129284-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3686210-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3441570-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0071129-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9802432-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9854167-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000191661-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006080574-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457454257
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID321710

Total number of triples: 45.